In/FW
vivo/FW
modification/NN
of/IN
major/JJ
histocompatibility/NN
complex/NN
class/NN
II/CD
DRA/NN
promoter/NN
occupancy/NN
mediated/VBN
by/IN
the/DT
AIR-1/NN
trans-activator/NN
./.

RJ/NN
2.2.5/CD
is/VBZ
a/DT
human/JJ
B/NN
cell/NN
mutant/NN
derived/VBN
from/IN
the/DT
Burkitt/NN
lymphoma/NN
Raji/NN
cell/NN
which/WDT
is/VBZ
defective/JJ
in/IN
the/DT
AIR-1/NN
locus/NN
function/NN
./.
=====
This/DT
locus/NN
encodes/VBZ
a/DT
transcriptional/JJ
trans-activator/NN
required/VBN
for/IN
the/DT
constitutive/JJ
expression/NN
of/IN
major/JJ
histocompatibility/NN
complex/NN
(/(
MHC/NN
)/)
class/NN
II/CD
genes/NNS
./.
=====
Here/RB
we/PRP
show/VBP
,/,
by/IN
in/FW
vivo/FW
DNase/NN
I/CD
footprinting/NN
,/,
that/IN
the/DT
AIR-1/NN
locus/NN
defect/NN
correlates/VBZ
with/IN
changes/NNS
in/IN
the/DT
DRA/NN
promoter/NN
occupancy/NN
./.
=====
Interestingly/RB
,/,
reexpression/NN
of/IN
human/JJ
MHC/NN
class/NN
II/CD
genes/NNS
in/IN
RJ/NN
2.2.5/CD
x/NN
mouse/NN
spleen/NN
cell/NN
hybrids/NNS
is/VBZ
associated/VBN
with/IN
partial/JJ
reversion/NN
of/IN
DRA/NN
promoter/NN
occupancy/NN
to/TO
the/DT
Raji/NN
pattern/NN
./.
=====
DRA/NN
promoter/NN
occupancy/NN
in/IN
other/JJ
class/NN
II-negative/JJ
B/NN
cell/NN
lines/NNS
,/,
derived/VBN
from/IN
patients/NNS
with/IN
bare/JJ
lymphocyte/NN
syndrome/NN
,/,
is/VBZ
drastically/RB
different/JJ
from/IN
the/DT
one/NN
observed/VBN
in/IN
RJ/NN
2.2.5/CD
and/CC
Raji/NN
cells/NNS
./.
=====
Moreover/RB
,/,
the/DT
use/NN
of/IN
the/DT
DNase/NN
I/CD
as/IN
an/DT
in/FW
vivo/FW
footprinting/NN
agent/NN
reveals/VBZ
that/IN
the/DT
patients/NNS
'/POS
cell/NN
lines/NNS
do/VBP
not/RB
display/VB
a/DT
completely/RB
"/``
bare/JJ
promoter/NN
"/''
as/IN
previously/RB
reported/VBN
using/VBG
dimethyl/JJ
sulfate/NN
as/IN
the/DT
footprinting/NN
agent/NN
./.
=====
Thus/RB
,/,
the/DT
use/NN
of/IN
DNase/NN
I/CD
allowed/VBD
us/PRP
,/,
for/IN
the/DT
first/JJ
time/NN
,/,
to/TO
correlate/VB
the/DT
AIR-1/NN
locus/NN
defect/NN
with/IN
class/NN
II/CD
promoter/NN
occupancy/NN
alterations/NNS
and/CC
distinguish/VB
these/DT
alterations/NNS
from/IN
the/DT
ones/NNS
observed/VBN
in/IN
phenotypically/RB
similar/JJ
but/CC
genetically/RB
distinct/JJ
MHC/NN
class/NN
II-negative/JJ
cells/NNS
./.